Evidence map›Paper›PMID 35251209›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2022

TCM-Based Therapy as a Rescue Therapy for Re-Eradication of

Mao-Feng Zhong, Jun Li, Xiao-Lin Liu, Peng Gong, Xiao-Tian Zhang

Abstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Jinghua Weikang capsule forFrontiers in pharmacology · 2022
    Pooled it
  2. Novel non-antibiotic triple therapy forFrontiers in medicine · 2026
    Article
  3. Helile formula from "Tai ping sheng hui fangFrontiers in cellular and infection microbiology · 2025
    Article
  4. 1,3,6-Trigalloylglucose: A Novel Potent Anti-Molecules (Basel, Switzerland) · 2024
    Article
  5. Chebulinic acid isolated from aqueous extracts ofFrontiers in microbiology · 2024
    Article
  6. Review
  7. Treatment of refractoryFrontiers in microbiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mao-Feng ZhongDepartment of Preventive Medicine, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.ORCID https://orcid.org/0000-0003-1938-6882
Jun LiDepartment of Traditional Chinese Medicine, The 940th Hospital of Chinese People's Liberation Army, Gansu Province, Lanzhou 730050, China.ORCID https://orcid.org/0000-0002-0099-3650
Xiao-Lin LiuDepartment of Gastroenterology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201900, China.ORCID https://orcid.org/0000-0002-0664-6027
Peng GongCharacteristic Diagnosis and Treatment Technology Research Institution Affiliated to Shanghai Institute of Traditional Chinese Medicine, Shanghai 201203, China.ORCID https://orcid.org/0000-0001-9568-0296
Xiao-Tian ZhangDepartment of Preventive Medicine, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.ORCID https://orcid.org/0000-0002-1400-6521

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increase in drug-resistant strains poses a severe challenge for

Identifiers

PMID35251209
PMCPMC8894008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.